相关实验视频
Updated: Jul 20, 2025

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
在左心室辅助装置植入后的右心力衰竭:一个持续的问题.
Chesney Siems1, Rishav Aggarwal1, Andrew Shaffer1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, 420 Delaware Street SE, MMC 207, Minneapolis, MN 55455 USA.
Indian journal of thoracic and cardiovascular surgery
|August 1, 2023
概括
右心力衰竭 (RHF) 是左心室辅助装置 (LVAD) 植入后的一种严重并发症. 本综述探讨了RHF病理生理学和心力衰竭患者的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭研究研究
背景情况:
- 左心室辅助器件 (LVAD) 对于等待移植或目的地治疗的末期心力衰竭患者至关重要.
- 右心力衰竭 (RHF) 是LVAD植入后的一个显著并发症,与高发病率和死亡率有关.
- 现有的RHF定义各不相同,通常涉及对右心室的特定医疗支持或机械援助的需要.
研究的目的:
- 在左心室辅助器件 (LVAD) 植入的背景下,审查右心力衰竭 (RHF) 的复杂病理生理学.
- 讨论目前和新兴的治疗策略,以管理LVAD后的RHF.
- 为临床医生和研究人员在先进的心力衰竭治疗领域提供全面的概述.
主要方法:
- 对LVAD和RHF研究的文献综述.
- 对导致RHF的病理生理机制的分析.
- 对RHF管理策略的临床数据的综合.
主要成果:
- 放射性高血压的病理生理包括心肌功能障碍,心室间依赖,以及右心室后负荷增加.
- 有效的管理需要解决这些潜在的机制.
- 早期识别和量身定制的治疗是改善结果的关键.
结论:
- 在LVAD植入后,右心力衰竭仍然是一个关键的挑战.
- 了解多因素病理生理学对于开发有效的治疗方案至关重要.
- 需要对向治疗进行进一步的研究,以减轻RHF并发症并改善患者的生存率.
相关概念视频
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure III: Clinical Manifestations
23
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23
Mitral Regurgitation I: Introduction
17
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
17
Heart Failure I: Introduction
16
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16

